Standard FDA review takes 10 to 12 months
Switching between Ozempic and other forms of semaglutide is possible
Improved body composition: Beyond weight loss, Tirzepatide also helps improve overall body composition by reducing fat and increasing lean muscle mass
But understand youre leaving significant results on the table compared to whats possible with properly dosed combination therapy targeting the GLP-1 and amylin receptor pathways simultaneously
Some patients may tolerate Trulicity better or prefer the simplicity of the single-use pens
(Most of the reform was ultimately abandoned after a series of successful court challenges, of which Novo Nordisk Canada was a party.) Thomas Digby, a B.C.-based intellectual-property lawyer and chair of the review board from 2023 to 2025, said that if its true that Novo abandoned its Ozempic/Wegovy patent in order to avoid PMPRB review, choosing instead to face generic entry, then its completely unprecedented in my experience, and quite possibly a strategic business mistake. Patent protections will lapse in India and Brazil in March, and in China and Turkey later in the year